Intelligence Platform

Patents

Browse 93 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8067445

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058226

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691872

Methods and compositions for optimizing blood and tissue stability of camptothecin and oth

New Century Pharmaceuticals, Inc. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632502

Cell wall mannoproteins and active epitopes from Candida albicans and antibodies recognizi

The Board of Regents of the University of Texas System · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488758

Levalbuterol hydrochloride polymorph B

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7482489

Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465831

Levalbuterol hydrochloride Polymorph A

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7253147

Modified serum albumin with reduced affinity for nickel and copper

New Century Pharmaceuticals, Inc. · Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247707

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208580

Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds

New Century Pharmaceuticals, Inc. · Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192546

Methods of forming shaped articles from suspensions

Albright & Wilson (Australia) Limited · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087723

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6949691

Human albumin animal models for drug evaluation, toxicology and immunogenicity studies

New Century Pharmaceuticals, Inc. · Granted Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6787636

Modified serum albumin with reduced affinity for nickel and copper

New Century Pharmaceuticals, Inc. · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6774219

Candida albicans gene, integrin-like protein, antibodies, and methods of use

Regents of the University of Minnesota · Granted Tue Aug 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6586573

Albumin-free Factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6525062

Method of treating pain using nalbuphine and opioid antagonists

The Regents of the University of California · Granted Tue Feb 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6433137

TUP1 sequences from Candida albicans and methods for screening agents for inhibiting virul

The Regents of the University of California · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6346411

DNA encoding—candida albicans integrin-like protein

Regents of the University of Minnesota · Granted Tue Feb 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6344554

Polynucleotide sequences from Candida albicans encoding polypeptides associated with filam

The Regents of the University of California · Granted Tue Feb 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6124278

Acylbenzoxazines for enhancing synaptic response

The Regents of the University of California · Granted Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired